AXGN 241220 12.50P (AXGN241220P12500) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

AXGN241220P12500

Watchlist

1.15
0.000.00%

15min DelayTrading Oct 28 14:08 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Those Who Invested in Axogen (NASDAQ:AXGN) a Year Ago Are up 98%
Yahoo FinanceDec 6 08:39 ET
Top Premarket Decliners
MT NewswiresDec 4 07:44 ET
All You Need to Know About AxoGen (AXGN) Rating Upgrade to Buy
Zacks Nov 28 11:15 ET
Is Axogen (NASDAQ:AXGN) A Risky Investment?
Simply Wall StNov 28 05:24 ET
How Much Upside Is Left in AxoGen (AXGN)? Wall Street Analysts Think 31.18%
Zacks Nov 25 09:05 ET
Top 10 Most Expensive Stocks (Only 1 Gets a Quant Sell)
Seeking AlphaNov 17 08:38 ET

Comments

Jsmooth420365

Sep 6 07:55

$AxoGen (AXGN.US)$ like it over 13.50

Cantor Fitzgerald sees AVITA's superior growth and high gross margins as reasons for a premium. The firm also sees potential in Pacific Biosciences and AxoGen, and expects positive share price appreciation for Exagen and NeuroPace. A significant catalyst for Nyxoah's stock is anticipated with upcoming DREAM study data.

Cantor Picks RCEL as Best 2024 Medtech Idea; Bullish on PACB, AXGN, CERS

Moomoo AI

Jan 7 09:21

AxoGen's EBIT loss and debt levels could strain its balance sheet despite its US$368.0m market cap. While revenue is growing, its financial performance is considered slow.

Does AxoGen (NASDAQ:AXGN) Have A Healthy Balance Sheet?

Moomoo AI

Dec 26, 2023 19:36

CEO of Axogen, Karen Zaderej is excited for Kathy Weiler to use her vast commercial knowledge to aid the company's goal of becoming cash flow positive. Weiler herself is equally fired up to be able to aid in Axogen's commercial success.

Press Release: Axogen, Inc. Appoints Kathy Weiler to Its Board of Directors